# A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)

> **NCT00235014** · PHASE4 · COMPLETED · sponsor: **Abbott** · enrollment: 1204 (actual)

## Conditions studied

- Hypertension
- Diabetes

## Interventions

- **DRUG:** trandolapril
- **DRUG:** trandolapril/verapamil
- **DRUG:** placebo
- **DRUG:** verapamil

## Key facts

- **NCT ID:** NCT00235014
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-03
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 1204 (ACTUAL)
- **Last updated:** 2008-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235014, "A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00235014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*